A Systematic Review of the Role of Penile Rehabilitation in Prostate Cancer Patients Receiving Radiotherapy and Androgen Deprivation Therapy

被引:5
作者
Doherty, Wesley [1 ]
Bridge, Pete [2 ]
机构
[1] Christie Hosp NHS Trust, Radiotherapy Dept, Manchester, Lancs, England
[2] Univ Liverpool, Directorate Radiotherapy, Liverpool, Merseyside, England
关键词
Prostate; radiotherapy; erectile dysfunction; penile rehabilitation; ERECTILE FUNCTION IIEF; QUALITY-OF-LIFE; SILDENAFIL CITRATE; RADIATION-THERAPY; DOUBLE-BLIND; PHOSPHODIESTERASE-5; INHIBITORS; RADICAL RADIOTHERAPY; INTERNATIONAL INDEX; OPEN-LABEL; DYSFUNCTION;
D O I
10.1016/j.jmir.2018.09.004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction/Background: Treatment-induced erectile dysfunction (ED) is a common side effect of radiotherapy and androgen deprivation therapy (ADT) that impacts on patient quality of life. Penile rehabilitation interventions including pharmacologic and physical therapies aim to reduce the impact of ED. Despite The National Institute for Health and Care Excellence guidelines recommending access to ED services, penile rehabilitation is not widely discussed or implemented. This systematic review aimed to appraise the evidence base for penile rehabilitation and identify evidence-based recommendations for practice. Methods: A systematic review of the evidence base was undertaken using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The Scopus and Medline (EBSCO) databases were searched for articles relevant to penile rehabilitation interventions for prostate radiotherapy patients. Study quality was graded using the Oxford Levels of Evidence and the Scottish Intercollegiate Guidelines Network. Results: This study identified 19 articles on penile rehabilitation in prostate radiotherapy patients, consisting of eight randomized controlled trials, three systematic reviews, and eight case studies. Findings confirmed the value of early use of phosphodiesterase type 5 inhibitors. Discussion: Despite the range of available physical and pharmaceutical interventions, relevant research focussed solely on the use of phosphodiesterase type 5 inhibitors. Themes from the reviewed articles indicated that timing of intervention was important with early on-going dosage most useful. There was also an identified need for ongoing prophylactic use during ADT. Evidence, in general, was of low quality and based on quantitative data only. Conclusion: Additional research into the wider range of penile rehabilitation interventions is urgently required to ensure patients have access to those therapies that are most appropriate for them. A paradigm shift toward qualitative research in the field of penile rehabilitation for prostate cancer patients treated with radiotherapy and ADT may be of value in future studies.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [31] Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysis
    Guo, Zhenlang
    Huang, Yiyu
    Gong, Leiliang
    Gan, Shu
    Chan, Franky Leung
    Gu, Chiming
    Xiang, Songtao
    Wang, Shusheng
    PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (04) : 451 - 460
  • [32] Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review
    Berdine L. Heesterman
    Katja K. H. Aben
    Igle Jan de Jong
    Floris J. Pos
    Olga L. van der Hel
    BMC Cancer, 23
  • [33] Cardiovascular events associated with androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis
    Carneiro, Arie
    Sasse, Andre Deeke
    Wagner, Andrew Aurel
    Peixoto, Guilherme
    Kataguiri, Andre
    Serpa Neto, Ary
    Vieira Bianco, Bianca Alves
    Chang, Peter
    Lima Pompeo, Antonio Carlos
    Tobias-Machado, Marcos
    WORLD JOURNAL OF UROLOGY, 2015, 33 (09) : 1281 - 1289
  • [34] Role of radiation and androgen deprivation therapy for advanced prostate cancer
    Jani, Ashesh B.
    Rossi, Peter J.
    CURRENT PROBLEMS IN CANCER, 2015, 39 (01) : 41 - 47
  • [35] Androgen Deprivation Therapy for Prostate Cancer
    Pagliarulo, Vincenzo
    MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES, 2019, 1126 : 1 - 30
  • [36] Androgen-deprivation therapy alone versus combined with radiation therapy or chemotherapy for nonlocalized prostate cancer: a systematic review and meta-analysis
    Lei, Jun-Hao
    Liu, Liang-Ren
    Wei, Qiang
    Song, Tu-Run
    Yang, Lu
    Meng, Yang
    Han, Ping
    ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (01) : 102 - 107
  • [37] Sleep Disturbance in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: The Role of Hot Flashes and Nocturia
    Gonzalez, Brian D.
    Small, Brent J.
    Cases, Mallory G.
    Williams, Noelle L.
    Fishman, Mayer N.
    Jacobsen, Paul B.
    Jim, Heather S. L.
    CANCER, 2018, 124 (03) : 499 - 506
  • [38] Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth
    Kaminski, JML
    Hanlon, AL
    Joon, DL
    Meistrich, M
    Hachem, P
    Pollack, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (01): : 24 - 28
  • [39] Androgen-Deprivation Therapy in Prostate Cancer: A European Expert Panel Review
    Schulman, Claude C.
    Irani, Jacques
    Morote, Juan
    Schalken, Jack A.
    Montorsi, Francesco
    Chlosta, Piotr L.
    Heidenreich, Axel
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (07) : 675 - 691
  • [40] A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy
    C Ellen Lee
    William D Leslie
    YK James Lau
    BMC Cancer, 12